EMEA-000265-PIP02-11-M03

Key facts

Invented name
Simponi
Active substance
Golimumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0157/2021
PIP number
EMEA-000265-PIP02-11-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of ulcerative colitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Janssen Biologics B.V.

Tel. +32 1460 2111
E-mail: contact@janssen-emea.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
2 ratings
2 ratings
1 rating